[1] Lipsky BA.A report from the international consensus on diagnosing and treating the infected diabetic foot [J].Diabetes Metab Res Rev,2004,20(Suppl 1):S68-S77. [2] Mazen S.Bader,王楚媛(译).糖尿病足感染[J].中国实用乡村医生杂志,2008,15(12):32-35. [3] 张彩霞,张彩萍.糖尿病足坏疽愈合的影响因素及护理[J].当代医学,2010,16(27):107-108. [4] Global Lower Extremity Amputation Study Group.Epidemiology of lower extremity amputation in centers in Europe,North America and East Asia[J].Br J Surg,2000,87(3):328-337. [5] Lavery LA,Armstrong DG,Murdoch DP,et al.Validation of the Infectious Diseases Society of America′s diabetic foot infection classification system[J].Clin Infect Dis,2007, 44(4):562-565. [6] 张杉杉,顾雪明,刘宏,等.糖尿病足感染病原菌分布与病情严重性相关[J].中华内分泌代谢杂志,2012,28(6):487-491. [7] 李宝军,关小宏,盛薇.系统化整体护理在糖尿病末梢神经病变治疗中的实用研究[J].中国医学研究与临床杂志,2005,3(8):103. [8] 韩国华,孙瑞霞,张丽萍,等.综合治疗糖尿病足溃疡32例分析[J].中国误诊学杂志,2001,1(6):931. [9] 许樟荣.糖尿病足病变诊断与治疗的临床思考[J].中国实用内科杂志,2005,25(4):377. [10] 黄少薇,陈永松,黄建英,等.糖尿病足的危险因素分析及护理干预对策[J].中国基层医药,2004,11(2):242-243. [11] 李超英,任智,姜健.糖尿病足的诊治进展[J].心肺血管杂志,2005,24(1):64. [12] Guzman-Gardeaizabal E,Leyva-Bohorquez G,Salas-Colin S,et al.Treatment of chronic ulcers in the lower extre mitice with topical becaplermingel .0.1%:a multicenter open-label study[J].Adv Ther,2002,17(4):184-189. [13] Boykin JV Jr.The nitric oxide connection:hyperbaric oxygen therapy,becaplermin,and diabetic ulcer management[J].Adv Skin Wound Care,2002,13(4 Pt 1):169-174. [14] 王爱红,赵浞,李强,等.中国部分省市糖尿病足调查及医学经济学分析[J].中华内分泌代谢杂志,2005,21(6):496-499. [15] van Battum P,Schaper N,Prompers L,et al.Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation[J].Diabet Med,2011,28(2):199-205. [16] 陈琼芳,李观妹.探讨糖尿病足的相关因素及护理干预对策[J].中国伤残医学,2014,22(9):266. [17] 曹秀颖,王俊.整体护理干预对糖尿病足患者的疗效观察[J].中国现代医生,2013,50(32):124-125. [18] 钱黎明.两种换药方法在糖尿病足溃疡中的应用及护理[J].中国现代医生,2012,49(33):84-85. |